Buckingham RE - Search Results

1

Potential defect in the vascular control of nonshivering thermogenesis in the obese Zucker rat hind limb.

Eldershaw TP, Rattigan S, Dora KA, Colquhoun EQ, Clark MG, Cawthorne MA, Buckingham RE. Eldershaw TP, et al. Among authors: buckingham re. Can J Physiol Pharmacol. 1994 Dec;72(12):1567-73. doi: 10.1139/y94-225. Can J Physiol Pharmacol. 1994. PMID: 7736349

2

Effects of intracerebroventricular infusion of leptin in obese Zucker rats.

al-Barazanji KA, Buckingham RE, Arch JR, Haynes A, Mossakowska DE, McBay DL, Holmes SD, McHale MT, Wang XM, Gloger IS. al-Barazanji KA, et al. Among authors: buckingham re. Obes Res. 1997 Sep;5(5):387-94. doi: 10.1002/j.1550-8528.1997.tb00660.x. Obes Res. 1997. PMID: 9385611

3

Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats.

Walker AB, Dores J, Buckingham RE, Savage MW, Williams G. Walker AB, et al. Among authors: buckingham re. Clin Sci (Lond). 1997 Sep;93(3):235-41. doi: 10.1042/cs0930235. Clin Sci (Lond). 1997. PMID: 9337638

4

Treatment with the thiazolidinedione (BRL 49653) decreases insulin resistance in obese Zucker hindlimb.

Eldershaw TP, Rattigan S, Cawthorne MA, Buckingham RE, Colquhoun EQ, Clark MG. Eldershaw TP, et al. Among authors: buckingham re. Horm Metab Res. 1995 Apr;27(4):169-72. doi: 10.1055/s-2007-979932. Horm Metab Res. 1995. PMID: 7750898

5

Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y.

Wang Q, Dryden S, Frankish HM, Bing C, Pickavance L, Hopkins D, Buckingham R, Williams G. Wang Q, et al. Br J Pharmacol. 1997 Dec;122(7):1405-10. doi: 10.1038/sj.bjp.0701535. Br J Pharmacol. 1997. PMID: 9421288 Free PMC article.

6

Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K. Sidell RJ, et al. Among authors: buckingham re. Diabetes. 2002 Apr;51(4):1110-7. doi: 10.2337/diabetes.51.4.1110. Diabetes. 2002. PMID: 11916933

7

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

Walker AB, Chattington PD, Buckingham RE, Williams G. Walker AB, et al. Among authors: buckingham re. Diabetes. 1999 Jul;48(7):1448-53. doi: 10.2337/diabetes.48.7.1448. Diabetes. 1999. PMID: 10389852

8

Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution.

Pickavance LC, Tadayyon M, Widdowson PS, Buckingham RE, Wilding JP. Pickavance LC, et al. Among authors: buckingham re. Br J Pharmacol. 1999 Dec;128(7):1570-6. doi: 10.1038/sj.bjp.0702932. Br J Pharmacol. 1999. PMID: 10602338 Free PMC article.

9

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.

Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K. Scheuermann-Freestone M, et al. Among authors: buckingham re. Circulation. 2003 Jun 24;107(24):3040-6. doi: 10.1161/01.CIR.0000072789.89096.10. Epub 2003 Jun 16. Circulation. 2003. PMID: 12810608 Clinical Trial.

10

Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat.

Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, Arch JR. Haynes AC, et al. Among authors: buckingham re. Peptides. 1999;20(9):1099-105. doi: 10.1016/s0196-9781(99)00105-9. Peptides. 1999. PMID: 10499428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results